Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Midterm 8 Multiple Choice Questions on Pharmacology with Answers | BIMM 118, Exams of Pharmacology

Material Type: Exam; Class: Pharmacology; Subject: Biology/Molec Biol, Microbiol; University: University of California - San Diego; Term: Winter 2008;

Typology: Exams

2009/2010

Uploaded on 03/28/2010

koofers-user-wvs
koofers-user-wvs 🇺🇸

5

(6)

10 documents

1 / 3

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
BIMM118 – Midterm ’08
NOTE: WRONG answers on multiple choice questions will result in the
DEDUCTION of the points !!!!!
1) A drug that is a partial agonist
a) binds to the same site on the receptor as the natural ligand
b) binds the receptor irreversibly
c) does not elicit a response from the receptor
d) shifts the dose-response curve of the natural ligand to the right
e) shifts the dose-response curve of the natural ligand to the right AND down
(5 pts each)
2) What are the Vd and t1/2? How are they interconnected (explain the underlying
concept!)?
Vd = volume of distribution; t1/2= half-life. Typically, drugs with a large Vd are highly
protein bound, and their metabolism/excretion is therefore attenuated. Consequently,
drugs with a large Vd have usually a longer half-life than drugs with small Vd.
(10 pts)
3) According to the diagram
a) Both drugs have the same efficacy
b) Drug B has higher efficacy
c) The drugs have different potency
d) Drug B has the lower potency
e) Drug A is a partial agonist
(5 pts each)
4) Provide an example of a food-drug interaction! Explain the underlying mechanism!
(10 pts)
*) Grapefruit juice contains a CYP3A4 inhibitor, thereby preventing oxidative metabolism of drugs
such as acetaminophen, codeine, warfarin, erythromycin etc.
*) MAO inhibitors (anti-depressant) also prevent the metabolism of tyramine, an amino acid found in
red wine and ripe cheeses. If not degraded by MAO, tyramine competes with (nor)epinephrine for
re-uptake and storage in presynaptic vesicles, thereby promoting sympathetic output.
pf3

Partial preview of the text

Download Midterm 8 Multiple Choice Questions on Pharmacology with Answers | BIMM 118 and more Exams Pharmacology in PDF only on Docsity!

BIMM118 – Midterm ’

NOTE: WRONG answers on multiple choice questions will result in the DEDUCTION of the points !!!!!

  1. A drug that is a partial agonist a) binds to the same site on the receptor as the natural ligand b) binds the receptor irreversibly c) does not elicit a response from the receptor d) shifts the dose-response curve of the natural ligand to the right e) shifts the dose-response curve of the natural ligand to the right AND down (5 pts each)
  2. What are the Vd and t1/2? How are they interconnected (explain the underlying concept!)? Vd = volume of distribution; t1/2= half-life. Typically, drugs with a large Vd are highly protein bound, and their metabolism/excretion is therefore attenuated. Consequently, drugs with a large Vd have usually a longer half-life than drugs with small Vd. (10 pts)
  3. According to the diagram a) Both drugs have the same efficacy b) Drug B has higher efficacy c) The drugs have different potency d) Drug B has the lower potency e) Drug A is a partial agonist (5 pts each)
  4. Provide an example of a food-drug interaction! Explain the underlying mechanism! (10 pts) *) Grapefruit juice contains a CYP3A4 inhibitor, thereby preventing oxidative metabolism of drugs such as acetaminophen, codeine, warfarin, erythromycin etc. *) MAO inhibitors (anti-depressant) also prevent the metabolism of tyramine, an amino acid found in red wine and ripe cheeses. If not degraded by MAO, tyramine competes with (nor)epinephrine for re-uptake and storage in presynaptic vesicles, thereby promoting sympathetic output.
  1. Which phases of the licensing process are aimed to establish the efficacy of a new drug candidate in humans: a) Preclinical studies b) Phase I c) Phase II d) Phase III e) Post-marketing surveillance (5 pts each)
  2. Which of the following modifications would be expected to increase lipid solubility of a drug: a) glucoronidation b) hydroxylation c) sulfation d) halogenation e) alkylation f) dealkylation (5 pts each)
  3. Glucocorticoids display a slow onset of action, but their effect persists after the drug has cleared the body. Why? Glucocorticoids mediate their actions through transcriptional responses via nuclear receptors. This delays the onset of their actions as transcription and translation events are involved, however, the newly induced proteins will still be present after the drug have cleared the body. (10 pts)
  4. Newer generation b-receptor antagonists are often referred to as “cardioselective b- blockers”. What is the basis for this organ-selectivity, and why is this of clinical relevance? Older b-receptor antagonists target b-receptor in the heart as well as b-receptors in the bronchii, leading to undesirable bronchoconstriction. Newer drugs are b-receptor selective antagonists. (5 pts each)
  5. How would food that increases the pH of the urine effect the excretion of a drug that is a weak acid? Explain your conclusion! An increase in the pH of the urine implies that more of a drug that is a weak acid exists in its ionized form in the urine. Increased ionization of the drug in the urine translates into increased accumulation of the drug in the urine=> increased excretion. (10 pts)
  6. Which of the following drugs would be useful in treating muscarine poisoning: a) Scopolamine b) Epinephrine c) Atropine d) Propranolol e) Succinylcholine (5 pts each)